Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Verschueren

Showing results (61-70 of 155) with videos related to

Pageof 16
Sort By:
Clinical Rheumatology|February 26, 2015
A maximum difference scaling survey of barriers to intensive combination treatment strategies with glucocorticoids in early rheumatoid arthritisSabrina Meyfroidt, Marlies Hulscher, Diederik De Cock, et al.
Clinical Rheumatology|September 27, 2023
Response to: comment on "validation and predictive capacity of a dutch version of the FLARE-RA questionnaire within the context of a TNFi-tapering trial"Michaël Doumen, Delphine Bertrand, Sofia Pazmino, et al.
Rheumatology (Oxford, England)|December 21, 2023
Patient-physician discordance impairs outcomes in early rheumatoid arthritis through less consistent treat-to-target implementationMichaël Doumen, Veerle Stouten, Sofia Pazmino, et al.
RMD Open|May 25, 2021
Short-term glucocorticoids reduce risk of chronic NSAID and analgesic use in early methotrexate-treated rheumatoid arthritis patients with favourable prognosis: subanalysis of the CareRA randomised controlled trialSofia Pazmino, Annelies Boonen, Diederik De Cock, et al.
Rheumatology (Oxford, England)|June 26, 2019
Effectiveness of different combinations of DMARDs and glucocorticoid bridging in early rheumatoid arthritis: two-year results of CareRAVeerle Stouten, René Westhovens, Sofia Pazmino, et al.
Seminars in Arthritis and Rheumatism|April 30, 2022
Psychological stress in rheumatoid arthritis: a systematic scoping reviewDiederik De Cock, Michaël Doumen, Charlotte Vervloesem, et al.
RMD Open|April 10, 2026
Immunoprecipitation-mass spectrometry reveals known and novel (NatC, <i>BCS1L</i>) antinuclear antibodies in rheumatoid arthritisJonas De Leeuw, Birthe Michiels, Rita Derua, et al.
RMD Open|October 27, 2022
Engagement and attrition with eHealth tools for remote monitoring in chronic arthritis: a systematic review and meta-analysisMichaël Doumen, Diederik De Cock, Caroline Van Lierde, et al.
RMD Open|September 24, 2025
Serum calprotectin and complement factor C3 are superior biomarkers of inflammation in early psoriatic arthritis as compared with C-reactive proteinAlla Ishchenko, Margot Van Mechelen, Sofia Pazmino, et al.
Acta Clinica Belgica|March 17, 2026
Prevalence of antisynthetase antibodies in a multicentre early rheumatoid arthritis cohortBram Mariën, Jean-Baptiste Vulsteke, Johan Joly, et al.
Pageof 16

Showing results (61-70 of 155) with videos related to

Sort By:
Pageof 16
Clinical Rheumatology|February 26, 2015
A maximum difference scaling survey of barriers to intensive combination treatment strategies with glucocorticoids in early rheumatoid arthritisSabrina Meyfroidt, Marlies Hulscher, Diederik De Cock, et al.
Clinical Rheumatology|September 27, 2023
Response to: comment on "validation and predictive capacity of a dutch version of the FLARE-RA questionnaire within the context of a TNFi-tapering trial"Michaël Doumen, Delphine Bertrand, Sofia Pazmino, et al.
Rheumatology (Oxford, England)|December 21, 2023
Patient-physician discordance impairs outcomes in early rheumatoid arthritis through less consistent treat-to-target implementationMichaël Doumen, Veerle Stouten, Sofia Pazmino, et al.
RMD Open|May 25, 2021
Short-term glucocorticoids reduce risk of chronic NSAID and analgesic use in early methotrexate-treated rheumatoid arthritis patients with favourable prognosis: subanalysis of the CareRA randomised controlled trialSofia Pazmino, Annelies Boonen, Diederik De Cock, et al.
Rheumatology (Oxford, England)|June 26, 2019
Effectiveness of different combinations of DMARDs and glucocorticoid bridging in early rheumatoid arthritis: two-year results of CareRAVeerle Stouten, René Westhovens, Sofia Pazmino, et al.
Seminars in Arthritis and Rheumatism|April 30, 2022
Psychological stress in rheumatoid arthritis: a systematic scoping reviewDiederik De Cock, Michaël Doumen, Charlotte Vervloesem, et al.
RMD Open|April 10, 2026
Immunoprecipitation-mass spectrometry reveals known and novel (NatC, <i>BCS1L</i>) antinuclear antibodies in rheumatoid arthritisJonas De Leeuw, Birthe Michiels, Rita Derua, et al.
RMD Open|October 27, 2022
Engagement and attrition with eHealth tools for remote monitoring in chronic arthritis: a systematic review and meta-analysisMichaël Doumen, Diederik De Cock, Caroline Van Lierde, et al.
RMD Open|September 24, 2025
Serum calprotectin and complement factor C3 are superior biomarkers of inflammation in early psoriatic arthritis as compared with C-reactive proteinAlla Ishchenko, Margot Van Mechelen, Sofia Pazmino, et al.
Acta Clinica Belgica|March 17, 2026
Prevalence of antisynthetase antibodies in a multicentre early rheumatoid arthritis cohortBram Mariën, Jean-Baptiste Vulsteke, Johan Joly, et al.
Pageof 16